We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $500B Turnover 17.13%
1-Year Est. Return 36.84%
 

Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.

This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+36.84%
3 Year Est. Return
+152.89%
5 Year Est. Return
+181.78%
10 Year Est. Return
+662.03%
AUM
$500B
AUM Growth
-$20.6B
Cap. Flow
-$19B
Cap. Flow %
-3.79%
Top 10 Hldgs %
39.98%
Holding
5,855
New
526
Increased
2,899
Reduced
1,490
Closed
477
Avg Time Held Equity + Options
5.6 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.9 years
Avg Time Held Equity only
6.5 years
Top 10 Avg Time Held Equity only
4.6 years
Top 20 Avg Time Held Equity only
5 years

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$17.5B
2
NVDA icon
NVIDIA
NVDA
+$2.7B
3
INTC icon
Intel
INTC
+$1.98B
4
AVGO icon
Broadcom
AVGO
+$1.46B
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.11B

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.47%
2 Technology 19.84%
3 Consumer Discretionary 7.61%
4 Financials 5.61%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DEM icon
4251
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.95B
$100K ﹤0.01%
1,800
– –
2026 Q1
2 quarters
DTCR icon
4252
Global X Data Center & Digital Infrastructure ETF
DTCR
$1.8B
$99.4K ﹤0.01%
3,661
+431
+13% +$12.1K
2026 Q2
1 quarter
PYXS icon
4253
Pyxis Oncology
PYXS
$169M
$98.5K ﹤0.01%
42,293
+37,624
+806% +$114K
2024 Q2
9 quarters
PEPG icon
4254
PepGen
PEPG
$290M
$98.4K ﹤0.01%
40,676
+36,287
+827% +$94K
2022 Q2
17 quarters
SES icon
4255
SES AI
SES
$163M
$98.4K ﹤0.01%
163,937
-13,731
-8% -$8.1K
2023 Q2
13 quarters
TNDM icon
4256
PUT
Tandem Diabetes Care
TNDM
$1.29B
$97.9K ﹤0.01%
6,000
-14,000
-70% -$263K
2026 Q1
2 quarters
LAW icon
4257
CS Disco
LAW
$434M
$97.5K ﹤0.01%
23,772
+6,315
+36% +$26.2K
2022 Q1
18 quarters
OKUR icon
4258
OnKure Therapeutics
OKUR
$113M
$97.3K ﹤0.01%
35,722
+4,002
+13% +$15.1K
2022 Q1
18 quarters
HRTX icon
4259
Heron Therapeutics
HRTX
$54.1M
$97.3K ﹤0.01%
310,479
+219,457
+241% +$83.2K
2014 Q2
49 quarters
KDK icon
4260
Kodiak AI
KDK
$220M
$97.2K ﹤0.01%
50,635
+31,122
+159% +$125K
2025 Q2
5 quarters
PPIH icon
4261
Perma-Pipe International
PPIH
$221M
$97.2K ﹤0.01%
3,159
+1,702
+117% +$46.2K
2025 Q3
4 quarters
NDLS icon
4262
Noodles & Co
NDLS
$56.7M
$96.4K ﹤0.01%
7,272
-24
-0.3% -$347
2016 Q2
41 quarters
UTMD icon
4263
Utah Medical Products
UTMD
$206M
$96.3K ﹤0.01%
1,300
+419
+48% +$29.9K
2020 Q2
25 quarters
TDACW icon
4264
Translational Development Acquisition Corp Warrants
TDACW
$8.54M
$96.2K ﹤0.01%
64,116
-6,376
-9% -$11K
2026 Q2
1 quarter
LPL icon
4265
LG Display
LPL
$2.51B
$96.1K ﹤0.01%
32,588
+28,121
+630% +$91.9K
2026 Q1
2 quarters
PTLO icon
4266
Portillo's
PTLO
$490M
$96.1K ﹤0.01%
27,214
+16,937
+165% +$75.1K
2022 Q1
18 quarters
AVNW icon
4267
Aviat Networks
AVNW
$214M
$95.6K ﹤0.01%
4,766
+2,893
+154% +$59.6K
2020 Q4
23 quarters
GAPR icon
4268
FT Vest US Equity Moderate Buffer ETF April
GAPR
$291M
$95.2K ﹤0.01%
2,236
– –
2024 Q3
8 quarters
FHDG icon
4269
FT Vest U.S. Equity Quarterly Dynamic Buffer ETF
FHDG
$74.7M
$94.8K ﹤0.01%
2,546
– –
2024 Q4
7 quarters
OGN icon
4270
Organon & Co
OGN
$3.65B
$94.6K ﹤0.01%
6,904
-100,072
-94% -$1.36M
2022 Q1
18 quarters
LFCR icon
4271
Lifecore Biomedical
LFCR
$243M
$94.5K ﹤0.01%
14,355
+6,420
+81% +$29.8K
2024 Q2
9 quarters
FEBT icon
4272
AllianzIM U.S. Equity Buffer10 Feb ETF
FEBT
$100M
$94.3K ﹤0.01%
2,238
– –
2026 Q2
1 quarter
OPRX icon
4273
OptimizeRx
OPRX
$125M
$93.4K ﹤0.01%
11,186
-3,799
-25% -$27.4K
2019 Q1
30 quarters
DDFO icon
4274
Innovator Equity Dual Directional 15 Buffer ETF - October
DDFO
$101M
$93.4K ﹤0.01%
4,065
– –
2026 Q1
2 quarters
FBYD icon
4275
Falcon's Beyond
FBYD
$261M
$93.3K ﹤0.01%
11,042
+6,451
+141% +$66.1K
2025 Q4
3 quarters

Similar funds

Barclays's Q3 2026 Portfolio in Review

As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays withdrew a net $19B in Q3 2026, closing 477 positions and reducing 1,490 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.

  • Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
  • Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
  • Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
  • Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
  • Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
  • Barclays opened 526 new positions and closed 477 in Q3 2026.
  • Barclays's portfolio value fell 4% quarter-over-quarter to $500B.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.